Parenteral 17beta-estradiol decreases fasting blood glucose levels in non-obese mice with short-term ovariectomy

Add time:08/16/2019    Source:sciencedirect.com

AimsLong-term ovariectomy-induced metabolic changes such as insulin resistance and glucose intolerance might be caused directly by estrogen deficiency and may occur partly as secondary effects of obesity arising due to the orexigenic effects of estrogen deficiency. Long-term estrogen treatment prevented those by exerting anorexigenic and metabolic actions in ovariectomized mice. However, the effect of short-term estrogen treatment on glucose metabolism in mice with short-term ovariectomy, during which ovariectomy-induced obesity does not develop, is not yet clear. The aim of this study was to evaluate the effect of short-term parenteral 17beta-estradiol treatment on glucose metabolism and blood glucose levels in mice at 2 weeks after ovariectomy, a time period during which ovariectomy-induced obesity does not develop.

We also recommend Trading Suppliers and Manufacturers of 17BETA(H)-HOP-21(22)-EN-3-ONE (cas 17152-56-6). Pls Click Website Link as below: cas 17152-56-6 suppliers

Prev:Functional aspects of 17beta-hydroxysteroid dehydrogenase 1 determined by comparison to a closely related retinol dehydrogenase☆
Next:Research report17Beta-estradiol blocks NMDA-induced increases in regional cerebral O2 consumption)